Related Experiment Video
Updated: May 21, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
PSPH and CXCL2 Predict Treatment Response in First-Episode Schizophrenia: a Retrospective Study.
Serum levels of Phosphoserine Phosphatase (PSPH) and Chemokine C-X-C Motif Ligand 2 (CXCL2) show promise as biomarkers. Elevated levels predict poor antipsychotic treatment response in male first-episode schizophrenia patients.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Psychiatry
Background:
- Schizophrenia treatment response prediction remains challenging.
- Identifying reliable biomarkers is crucial for personalized medicine.
Purpose of the Study:
- To evaluate serum Phosphoserine Phosphatase (PSPH) and Chemokine C-X-C Motif Ligand 2 (CXCL2) levels.
- To assess their potential as predictive biomarkers for antipsychotic treatment efficacy.
- Focus on male first-episode schizophrenia patients.
Main Methods:
- Retrospective analysis of 297 male patients treated with olanzapine.
- Serum PSPH and CXCL2 levels measured by ELISA.
- Receiver Operating Characteristic (ROC) and logistic regression analyses performed.
Main Results:
- Non-improvement group showed significantly higher serum PSPH and CXCL2 levels.
- Both biomarkers positively correlated with Positive and Negative Syndrome Scale (PANSS) scores.
- Combined PSPH and CXCL2 levels demonstrated a high predictive performance (AUC = 0.823).
Conclusions:
- Serum PSPH and CXCL2 levels are potential predictive biomarkers for antipsychotic treatment response.
- These biomarkers may aid in optimizing treatment strategies for schizophrenia.
- Further validation in diverse patient populations is warranted.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...